AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Feb 2008 06:00 PM
RNS
Director/PDMR Shareholding
27 Feb 2008 06:00 PM
RNS
Director/PDMR Shareholding
27 Feb 2008 06:00 PM
RNS
Director/PDMR Shareholding
27 Feb 2008 07:02 AM
RNS
Recentin
22 Feb 2008 07:00 AM
RNS
Alabama Pricing Case
18 Feb 2008 11:00 AM
RNS
Directorate Change
04 Feb 2008 05:14 PM
PRN
MedImmune Submits Biologics License Application...
04 Feb 2008 05:00 PM
RNS
Regulatory Application
31 Jan 2008 04:00 PM
RNS
Total Voting Rights
31 Jan 2008 11:00 AM
RNS
Final Results - Part 3 of 3
31 Jan 2008 11:00 AM
RNS
Final Results - Part 2 of 3
31 Jan 2008 11:00 AM
RNS
Final Results - Part 1 of 3
30 Jan 2008 10:00 AM
RNS
Notice of Results
08 Jan 2008 04:00 PM
RNS
Director/PDMR Shareholding
02 Jan 2008 04:30 PM
RNS
Total Voting Rights
20 Dec 2007 03:36 PM
PRN
MedImmune Expands Scientific and Engineering Le...
20 Dec 2007 03:00 PM
RNS
Holding(s) in Company
17 Dec 2007 07:00 AM
RNS
Transaction in Own Shares
14 Dec 2007 10:00 PM
PRN
New Results From one of the World's Largest Bre...
14 Dec 2007 10:00 PM
PRN
New Results From One of the World's Largest Bre...
14 Dec 2007 07:00 AM
RNS
Transaction in Own Shares
13 Dec 2007 07:01 AM
RNS
Transaction in Own Shares
12 Dec 2007 07:01 AM
RNS
Crestor ANDAs
12 Dec 2007 07:00 AM
RNS
Transaction in Own Shares
11 Dec 2007 07:00 AM
RNS
Transaction in Own Shares
07 Dec 2007 11:05 AM
PRN
AstraZeneca - Biologics Day Interviews With Sen...
07 Dec 2007 10:00 AM
RNS
Research Update
06 Dec 2007 11:00 AM
RNS
Holding(s) in Company
05 Dec 2007 05:00 PM
RNS
Director/PDMR Shareholding
30 Nov 2007 04:30 PM
RNS
Total Voting Rights
29 Nov 2007 07:00 AM
RNS
Transaction in Own Shares
27 Nov 2007 07:00 AM
RNS
Transaction in Own Shares
26 Nov 2007 01:30 PM
PRN
MedImmune Initiates First Clinical Trial of Mon...
21 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
20 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
19 Nov 2007 05:00 PM
RNS
Director/PDMR Shareholding
19 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
16 Nov 2007 07:00 AM
RNS
Transaction in Own Shares
13 Nov 2007 07:00 AM
RNS
Transaction in Own Shares
09 Nov 2007 07:04 AM
RNS
Crestor
09 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
08 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
07 Nov 2007 04:00 PM
PRN
New Analysis of the Meteor Study Demonstrate th...
07 Nov 2007 07:01 AM
RNS
Pricing of Bond Issue
06 Nov 2007 03:39 PM
RNS
Publication of Prospectus
06 Nov 2007 07:00 AM
RNS
Transaction in Own Shares
05 Nov 2007 01:00 PM
PRN
New Data Examines the Effect of Adding a Statin...
05 Nov 2007 07:01 AM
RNS
Transaction in Own Shares
01 Nov 2007 11:00 AM
RNS
3rd Quarter Results - 2 of 2
01 Nov 2007 11:00 AM
RNS
3rd Quarter Results - 1 of 2
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings